Jyong Biotech LTD. Ordinary Shares reports a Return on Equity (ROE) of 18.75%.

What is MENS's dividend yield?

Jyong Biotech LTD. Ordinary Shares offers a dividend yield of 0.00%.

What is MENS's Quality Score?

Our AI rates MENS's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy MENS?

Our AI Timing Score for MENS is 55 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does MENS belong to?

Jyong Biotech LTD. Ordinary Shares is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Jyong Biotech LTD. (MENS) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2025-12-31)

MENS AI Analysis Summary

Our AI summary for MENS: Jyong Biotech LTD. Ordinary Shares (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of 18.75%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 55/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

MENS

Jyong Biotech LTD. Ordinary Shares

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 2.04

0.04 (2.00%) Day Change

Watchlist Portfolio Compare Chart

-0.74

D/E

18.8%

ROE

-22.5%

ROA

0.00%

Div Yield

JYONG BIOTECH LTD. ORDINARY SHARES
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.04 Price 0.04 (2.00%) Day Change	NEWS SCORE: N/A

MENS, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROA is relatively low.
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.04
PBV / Sector	-6.08 / 44,022.72
Earning Per Share	-0.06

PE / Sector	N/A / 19.17
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	0.14 M GREAT
Average 1W Daily Value	0.13 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.24
NPM Average (%) / Sector	N/A / -1,697.63
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-22.48 / 185,260.96
ROA Average (%) / Sector	-49.77 / 36,684.70
ROA Change Average (%) / Sector	-31.11 / 422,221.66
ROE (%) / Sector	18.75 / 243,762.23
ROE Average (%) / Sector	15.58 / 48,758.47
ROE Change Average (%) / Sector	16.20 / 424,968.10 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 08:00:31
Symbol	MENS
Name	JYONG BIOTECH LTD. ORDINARY SHARES
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	74.23 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	151.44 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: No. 95, Xintai 5th Road, New Taipei City, Taiwan, 221

Phone: 886 2 2732 5205

Website: https://jyongbio.com

Sector: Healthcare >> Biotechnology

Description: Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.